IONCOLOGI

ioncologi-logo

iOncologi specializing in immuno-oncology. Launched as a โ€œspin-outโ€ cancer immunotherapy firm from the University of Florida, iOiโ€™s founders have developed a novel stem cell therapy that overcomes resistance to immune checkpoint inhibitors in multiple cancers.

#Website #More

IONCOLOGI

Industry:
Biotechnology Therapeutics

Address:
Gainesville, Florida, United States

Country:
United States

Website Url:
http://www.ioncologi.com

Total Employee:
1+

Status:
Active

Contact:
(352) 559-5100


Official Site Inspections

http://www.ioncologi.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "iOncologi"

iOncologi - Home Page

IOncologi Founder and President, Duane A. Mitchell, MD, PhD, is an internationally renowned leader in brain tumor immunotherapy with extensive experience in the immunologic treatment โ€ฆSee details»

iOncologi - Crunchbase Company Profile & Funding

IOncologi is a biotechnology company specializing in immuno-oncology. iOncologi specializing in immuno-oncology. Launched as a โ€œspin-outโ€ cancer โ€ฆSee details»

iOncologi 2025 Company Profile: Valuation, Funding & Investors

IOncologi General Information Description. Operator of a biotechnology company intended to focus on novel immunotherapies for the treatment of refractory cancers and infectious โ€ฆSee details»

IONCOLOGI, INC. Company Profile | Gainesville, FL | Competitors ...

Find company research, competitor information, contact details & financial data for IONCOLOGI, INC. of Gainesville, FL. Get the latest business insights from Dun & Bradstreet.See details»

iOncologi - Funding, Financials, Valuation & Investors - Crunchbase

Mar 14, 2025 iOncologi has acquired TargImmune Therapeutics on Mar 14, 2025. Acquisitions. Edit Acquisitions Section. ... 2025. Which types of acquisition does this organization make โ€ฆSee details»

iOncologi - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

iOncologi, Inc.

IOncologi, Inc. News office: United States Phones Phone news office: ... Media relations professionals can connect with reporters and share their organization's news with a wider โ€ฆSee details»

iOncologi - Products, Competitors, Financials, Employees, โ€ฆ

IOncologi is a biotechnology company specializing in immuno-oncology. Use the CB Insights Platform to explore iOncologi's full profile. iOncologi - Products, Competitors, Financials, โ€ฆSee details»

Ioncologi, Inc. Gainesville, FL - filing information

Mar 20, 2018 Ioncologi, Inc., a Foreign Profit Corporation, is a business entity located in Gainesville, FL. Officially filed on March 20, 2018, this corporation is recognized under the โ€ฆSee details»

iOncologi, Inc. | Insights

Mar 26, 2025 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

IONCOLOGI, INC. - Drug pipelines, Patents, Clinical trials - Synapse

Explore IONCOLOGI, INC. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:iOi-7.See details»

iOncologi - Overview, News & Similar companies | ZoomInfo.com

View iOncologi (www.ioncologi.com) location in Florida, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

iOncologi Appoints Dr. Mona Flores and Mr. Paolo Fundarò to Board

Mar 17, 2025 iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of โ€ฆSee details»

iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and ...

Mar 16, 2025 The acquisition aligns with iOncologi's broader strategy to expand its therapeutic pipeline, leverage next-generation RNA-based immunotherapies, and drive innovation in โ€ฆSee details»

iOncologi, Inc. Announces the Appointment of Dr. Mona Flores

GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ -- iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer โ€ฆSee details»

Immunomic Therapeutics Announces Collaboration With iOncologi

Nov 23, 2021 iOncologi, Inc. (iOi) is a privately held biotechnology company focused on the advancement of novel immunotherapies for the treatment of refractory cancers and infectious โ€ฆSee details»

iOncologi, Inc. Announces the Appointment of Dr. Mona Flores โ€ฆ

Mar 17, 2025 iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of โ€ฆSee details»

iOncologi Welcomes New Board Members to Enhance Leadership โ€ฆ

Mar 17, 2025 iOncologi Strengthens Leadership with New Board Appointments. iOncologi, Inc., a pioneering biopharmaceutical company focused on developing innovative immunotherapies โ€ฆSee details»

iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and ...

Mar 14, 2025 iOncologi, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative immunotherapies for the treatment of solid tumors. The company โ€ฆSee details»

Nextsource | Company Profile | IOncologi

Monitor if IOncologi is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. Learn about mergers or acquisitions involving IOncologi . Uncover shifts in โ€ฆSee details»